Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine versus placebo in irritable bowel syndrome with diarrhea
IRCT20120215009014N311Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Diarrhea-predominant irritable bowel syndrome (IBS-D) comparing Mirtazapine with Placebo (2 arms). Started Nov 2019; status: completed.
02
Drugs
mirtazapine
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on IRCT20120215009014N311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N311.